ELVN Enliven Therapeutics, Inc.

HealthcareBiotechnology
$40.29
▼ 2.21%
39
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
30
Short-Term
48

Value

30
P/E-25.62
8
P/B5.58
44
P/S0.00
70
EV/EBITDA-20.98
5

Growth

38
Revenue Growth0.0%
28
EPS Growth3.2%
43
FCF Growth3.8%
45

Momentum

78
12-Month Return104.6%
100
3-Month Return49.3%
100
1-Month Return-6.1%
42
RSI (14)13.73
60
50/200 MABullish
75

Profitability

20
ROE-21.0%
47
ROA-21.2%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-2.7%
0

Risk

25
Beta0.45
55
60-Day Volatility63.4%
0

Generated 5/7/2026, 10:05:19 PM · How is this calculated?

QScore Analysis